Active

    Veeda Clinical Research Limited

    Looking to invest in ? Open a Demat account in minutes.

    Veeda Clinical Research Limited IPO Details

    Listing Date

    -

    Bid Price

    ₹0 - ₹0

    Lot Size

    0 Shares

    Minimum Investment

    ₹

    Issue Size

    ₹0 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    -

    tick

    Offer End Date

    -

    tick

    Allotment Date

    -

    tick

    Refund Initiation

    -

    tick

    Demat Transfer

    -

    tick

    Listing Date

    -

    Veeda Clinical Research Limited Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 0% 0%
    Public Group 100% 100%

    Veeda Clinical Research Limited IPO Reservation

    QIB Shares Offered 0 (0%)
    NII (HNI) Shares Offered 0 (0%)
    Retail Shares Offered 0 (0%)
    Anchor Investor Shares Offered 0 (0%)
    Total Shares Offered 0
    Total Shares With Anchor Investor 0

    Veeda Clinical Research Limited IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) [-] [-] ₹[-]
    Retail (Max) [-] [-] ₹[-]
    S HNI (Min) [-] [-] ₹[-]
    S HNI (Max) [-] [-] ₹[-]
    B HNI (MIN) [-] [-] ₹[-]

    Veeda Clinical Research Limited IPO registrar

    MUFG Intime India Pvt Ltd
    Phone Number + 91 81081 14949
    Email Id Veedalifesciences.ipo@linkintime.co.in
    Website https://in.mpms.mufg.com

    Veeda Clinical Research Limited IPO Lead Manager

    1. Axis Capital Ltd

    2. CLSA India Pvt ltd

    3. IIFL Capital Services Ltd

    4. SBI Capital Markets Ltd

    Veeda Clinical Research Limited Financial Information

    March 31, 2025 March 31, 2024 March 31, 2023
    Net Worth ₹855.76 Cr ₹1,059.97 Cr ₹457.16 Cr
    Reserves and Surplus ₹842.6 Cr ₹1,047.37 Cr ₹446.58 Cr
    Total Borrowing ₹405.97 Cr ₹261.68 Cr ₹48.57 Cr

    Strength of Veeda Clinical Research Limited

    • A platform for drug development needs of customers.
    • Successful integration of growth opportunities through acquisitions.
    • Strong scientific capabilities across business services.
    • Established quality credentials with a strong focus on quality control management.
    • Global and diverse management team with deep scientific expertise.

    Risks Involved

    • The company derives a significant portion of its revenue from contracts with the company top clients. Its top five clients contributed more than 41.16% of the company revenue from contract with customers in the six months period ended September 30, 2024 with its top client that contributed approximately 28.37% of the company revenue from contract with customers in the six months period ended September 30, 2024. Loss of any of these clients could adversely affect its business, results of operations, cash flows and financial condition.
    • The potential loss or delay under any of its large contracts or of multiple key client contracts could adversely affect the company financial results specifically since the relationship of backlog to revenues varies over time and may not be fully realisable in the event of contract cancellation.
    • The company required to perform its services in accordance with contractual requirements, regulatory standards in applicable jurisdictions and ethical considerations. Any adverse action by any authority, including the Food and Drug Administration or the European Medicines Agency against it would negatively impact on the company ability to offer its services to the company clients and adversely impact its business and prospects.
    • If the company fails to deliver services in accordance with contractual requirements, the company could be subject to significant costs or liability and its reputation could be harmed.
    • The company has incurred losses for the six months period ended September 30, 2024 and Financial Year 2024 and may continue to do so in the future, which may adversely impact its business and the value of the Equity Shares.
    • The company financial performance is dependent on the company ability to secure business from clients in the pharmaceutical and biopharmaceutical industry. Consequently, any adverse changes in outsourcing trends in the pharmaceutical and biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect its operating results and growth rate.
    • The company studies and clinical trials could subject it to potential liability that may adversely affect its business, results of operations, cash flows and financial condition.
    • The company may not derives the anticipated benefits from its strategic investments and acquisitions, including the company acquisition of Heads and its may not be successful in pursuing future investments and acquisitions.
    • Failures to maintain confidential information of the company clients could adversely affect its business, results of operations, cash flows and financial condition and/or reputation.
    • The company is subject to risks arising from interest rate which could adversely affect its business, results of operations, cash flows and financial condition.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    • All
    • MainBoard
    • SME
    Bidding Period
    18th Nov 2026 - 11th Nov 2026
    Price Range
    ₹259.0 - 272.0
    IPO Size
    ₹4,55,71,00,032
    Watrana Rentals Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    19th Nov 2026 - 11th Nov 2026
    Price Range
    ₹232.0 - 245.0
    IPO Size
    ₹1,20,09,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Anjali LabTech Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    ANTALA INDUSTRIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹62.0 - 66.0
    IPO Size
    ₹22,98,00,000
    VEDANT POLY FABS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    2nd Nov 2026 - 11th Nov 2026
    Price Range
    ₹88.0 - 94.0
    IPO Size
    ₹56,68,00,000
    HGS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Oct 2026 - 11th Nov 2026
    Price Range
    ₹114.0 - 120.0
    IPO Size
    ₹34,56,00,000
    Bidding Period
    30th Oct 2026 - 11th Nov 2026
    Price Range
    ₹150.0 - 158.0
    IPO Size
    ₹57,64,00,000
    Bidding Period
    30th Oct 2026 - 11th Nov 2026
    Price Range
    ₹190.0 - 200.0
    IPO Size
    ₹56,02,00,000
    VECTRAS ENPROCON LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Oct 2026 - 11th Nov 2026
    Price Range
    ₹99.0 - 105.0
    IPO Size
    ₹53,05,00,000
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    CARVER ROBOWELD LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹28,29,00,000
    AJWA PROJECTS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹203.0 - 203.0
    IPO Size
    ₹38,05,00,000
    M K SONS FINE JEWELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹153.0 - 162.0
    IPO Size
    ₹2,75,39,99,872
    BLS POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    WISCON INDUSTRIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,65,98,528
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    ANTALA INDUSTRIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    66.00
    Listing Day Close
    50.16(-24.24%)
    HGS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    120.00
    Listing Day Close
    168.00(40.00%)
    Issue Prize
    158.00
    Listing Day Close
    315.20(99.37%)
    Issue Prize
    200.00
    Listing Day Close
    237.70(19.00%)
    VECTRAS ENPROCON LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    105.00
    Listing Day Close
    107.50(2.86%)
    VEDANT POLY FABS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    89.30(-5.32%)
    Issue Prize
    82.00
    Listing Day Close
    94.61(15.85%)
    CARVER ROBOWELD LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    80.00
    Listing Day Close
    94.50(18.75%)
    AJWA PROJECTS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    203.00
    Listing Day Close
    192.85(-4.93%)
    M K SONS FINE JEWELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    162.00
    Listing Day Close
    162.20(0.00%)
    BLS POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    150.00
    Listing Day Close
    269.30(79.33%)
    Issue Prize
    330.00
    Listing Day Close
    424.85(28.79%)
    WISCON INDUSTRIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    204.00
    Listing Day Close
    203.55(0.00%)
    Issue Prize
    1665.00
    Listing Day Close
    1727.05(3.72%)
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    93.00
    Listing Day Close
    78.12(-16.13%)
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    1119.00
    Listing Day Close
    1417.35(26.63%)
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    693.00
    Listing Day Close
    737.15(6.35%)
    Issue Prize
    344.00
    Listing Day Close
    378.20(9.88%)

    Frequently Asked Questions

    What is Veeda Clinical Research Limited IPO?

    Veeda Clinical Research Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on .

    When Veeda Clinical Research Limited IPO will open?

    The Veeda Clinical Research Limited IPO opens on [-] and closes on [-].

    What is the lot size of Veeda Clinical Research Limited?

    Veeda Clinical Research Limited lot size is [-] shares, and the minimum amount required is ₹[-].

    How to apply for Veeda Clinical Research Limited IPO?

    You can apply in Veeda Clinical Research Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Veeda Clinical Research Limited IPO allotment?

    The finalization of Basis of Allotment for Veeda Clinical Research Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

    When is Veeda Clinical Research Limited IPO listing date?

    The Veeda Clinical Research Limited listing date is [-].

    Who is the registrar of Veeda Clinical Research Limited IPO?

    The registrar of Veeda Clinical Research Limited IPO is MUFG Intime India Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    Axis Capital Ltd,CLSA India Pvt ltd,IIFL Capital Services Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Veeda Clinical Research Limited IPO?

    The fresh issue size is ₹[-] Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Veeda Clinical Research Limited?

    Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

    How can I approve the UPI mandate request for Veeda Clinical Research Limited IPO?

    To apply for Veeda Clinical Research Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Veeda Clinical Research Limited?

    The price of each Veeda Clinical Research Limited share will be ranging in between ₹[-] to ₹[-] per share.

    What is the cut-off time for the UPI mandate for Veeda Clinical Research Limited IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |